In the ongoing controversy over whether and how to use a powerful new genome editing technology in the wild to achieve conservation and public health goals, two new papers urge caution.

Jason Delborne addresses CRISPR gene drives controversy in NYTimes, Quanta, and Gizmodo

November 17, 2017 | Patti Mulligan

GES Faculty member Jason Delborne addresses two controversial new papers in several articles published this week on the safety of field testing CRISPR gene drives in the wild. With links to articles in New York Times, Quanta, Gizmodo and The Atlantic....

Continue reading "Jason Delborne addresses CRISPR gene drives controversy in NYTimes, Quanta, and Gizmodo"

Todd Kuiken quoted in Atlantic article on failure of glowing plant kickstarter

April 28, 2017 | Patti Mulligan

Remember the Kickstarter campaign that raised half a million dollars to fund the invention of glowing houseplants? Todd Kuiken, GES research scholar and synthetic biology expert, weighs in on the recent announcement of the project’s failure...

Continue reading "Todd Kuiken quoted in Atlantic article on failure of glowing plant kickstarter"